Lobbying Filing Details

Total Spending

$80,000

Activities

5

Lobbyists

4

Gov't Entities

11

Filing Information
Filing UUID:
665ad769-2acd-4482-9978-3c681774b4fe
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2026 at 6:54 PM
Income:
$80,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Isabella Quinn
Registrant
WILLIAMS AND JENSEN, PLLC

Lobbying Law Firm

Washington, District of Columbia
Client
BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.)

Healthcare/Pharmaceuticals

Massachusetts, United States of America
Lobbying Activities (5)
Activity 1
Health Issues

Monitor progress of next Prescription Drug User Fee Reauthorization, issues relating to US and international manufacturing, oncology issues, FDA reorganization and programs, 340B, monitoring efforts around direct-to-consumer policies.

Lobbyists (3)
  • SUSAN HIRSCHMANN
  • MR. MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Manufacturing

Monitoring efforts to onshore and build US pharmaceutical manufacturing capacity.

Lobbyists (3)
  • SUSAN HIRSCHMANN
  • MR. MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Medicare/Medicaid

Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing), access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.

Lobbyists (3)
  • SUSAN HIRSCHMANN
  • MR. MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
Activity 4
Pharmacy

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Lobbyists (3)
  • SUSAN HIRSCHMANN
  • MR. MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 5
Trade (domestic/foreign)

Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.

Lobbyists (4)
  • SUSAN HIRSCHMANN
  • MR. CHRISTOPHER W HATCHER
  • MR. MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.